← Leaderboards
Susan A Farr
Saint Louis University
$1,794,229
Attributed
$3,588,457
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $875.4K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,588,457 · 3
VA$0 · 1
By mechanism
R01$3,171,832 · 2
R21$416,625 · 1
I01$0 · 1
Top collaborators
- Daniela Salvemini8 shared
- Andrew Alistair Butler1 shared
Most similar at Saint Louis University
Same institution · by research overlap
- Monica N. Goodland$79,330
Others in their field
Top investigators on “Learning”
- Praduman Jain · Vignet, Inc.$145,457,385
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$140,113,248
- Greg Ulses · Consortium For Ocean Leadership, Inc$140,113,248
- Mary L. Disis · University Of Washington$129,059,152
- Lee Marshall Nadler · Dana-Farber Cancer Inst$124,071,843
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$115,886,990
Research focus
LearningBrainMemoryDoseResponseAffectReportingCognitive FunctionMaleLinkSignal TransductionPreventImpaired CognitionAnxietyInterleukin-1 BetaFemaleFda ApprovedGenetic ApproachMedicalInsightAmericanAttentionInflammatoryInterdisciplinary Approach
Grant awards (13)
Fingolimod and Ozanimod for the treatment and prevention of chemobrain$502,411
R01 · FY2025 · CA
Fingolimod and Ozanimod for the treatment and prevention of chemobrain$458,752
R01 · FY2024 · CA
An investigation of the response of preclinical mouse models of dementia to adropin therapy$416,625
R21 · FY2024 · AG
Fingolimod and Ozanimod for the treatment and prevention of chemobrain$461,866
R01 · FY2023 · CA
Novel therapeutic approaches for traumatic brain injury induced cognitive deficits$331,406
R01 · FY2023 · NS
Fingolimod and Ozanimod for the treatment and prevention of chemobrain$442,415
R01 · FY2022 · CA
Novel therapeutic approaches for traumatic brain injury induced cognitive deficits$331,406
R01 · FY2022 · NS
Novel therapeutic approaches for traumatic brain injury induced cognitive deficits$318,661
R01 · FY2021 · NS
Novel therapeutic approaches for traumatic brain injury induced cognitive deficits$324,915
R01 · FY2020 · NS
Antisense Oligonucleotide Treatment for Alzheimer's Disease$0
I01 · FY2013 · VA · contact PI
Antisense Oligonucleotide Treatment for Alzheimer's Disease$0
I01 · FY2012 · VA · contact PI
Antisense Oligonucleotide Treatment for Alzheimer's Disease$0
I01 · FY2011 · VA · contact PI
Antisense Oligonucleotide Treatment for Alzheimer's Disease$0
I01 · FY2009 · VA · contact PI